The authors were of the view that in mouse melanoma B16 cells, BBR reversed the epithelial to mesenchymal transition and hence can be used as an effective anticancer agent in treating melanoma via regulation of the PI3K/Akt pathway [112]. The gene discussed is AKT1; the disease is melanoma.